You are here
Home > News > New Structure of Key Protein Holds Clues for Better Drug Design

New Structure of Key Protein Holds Clues for Better Drug Design

odies.

In addition to Wthrich and Eddy, authors of the study, “Allosteric Coupling of Drug Binding and Intracellular Signaling in the A2a Adenosine Receptor,” were Tatiana Didenko and Pawel Stanczak of The Scripps Research Institute; Reto Horst of The Scripps Research Institute and Pfizer Worldwide Research and Development; Zhan-Guo Gao and Kenneth A. Jacobson of the National Institutes of Health; and Ming-Yue Lee, Kyle M. McClary, Gye Won Han, Martin Audet, Kate L. White and Raymond C. Stevens of the University of Southern California.

This study was supported by the National Institutes of Health’s (NIH) National Institute of General Medical Sciences (grants U54 GM094618 and R01GM115825), the NIH National Institute of Diabetes and Digestive and Kidney Diseases Intramural Research Program and the American Cancer Society.

Leave a Reply

Top